Skip to main content
. Author manuscript; available in PMC: 2011 Oct 12.
Published in final edited form as: Cochrane Database Syst Rev. 2009 Oct 7;(4):CD006690. doi: 10.1002/14651858.CD006690.pub2
Methods Parallel randomised controlled trial

Participants SETTING: inpatients and outpatients at Huaian County Hospital
WHO PARTCIPATED: n=60 (30 in treatment group, M/F 21/9, mean age 48yrs and 30
in control group, M/F 17/13, mean age 49yrs)
INCLUSION CRITERIA: IGT (ADA 1997)
EXCLUSION CRITERIA: none reported
CO-MORBIDITIES: none reported
CO-MEDICATIONS: none reported

Interventions INTERVENTION: Tang ping san (Huang Qi 30g, Shan Yao 10g, Sheng Di Huang 10g,
Shu Di Huang 10g, Gou Qi Zi 10g, He Shou Wu 10g, Xian Ling Pi 10g, Dan Shen 30g,
Ze Xie 10g, Sang Ye 10g), oral, decoction, once per day (b.i.d), plus lifestyle
modification (diet & lifestyle advice)
CONTROL: Metformin, oral, 0.25g per dose, three times a day (t.i.d), plus lifestyle
modification (diet & lifestyle advice)

Outcomes 2hr-GTT (mmol/L) measured at baseline, at trial completion (3 months) and at follow-
up (6 months)

Study details DURATION OF INTERVENTION: 12 weeks
DURATION OF FOLLOW-UP: 3 months
RUN-IN PERIOD: none

Publication details LANGUAGE OF PUBLICATION: Chinese
COMMERCIAL FUNDING: No
NON-COMMERCIAL FUNDING: Yes (Scientific research funding by Municipal
Government).
PUBLICATION STATUS (PEER REVIEW JOURNAL): Yes
PUBLICATION STATUS (JOURNAL SUPPLEMENT): no
PUBLICATION STATUS (ABSTRACT): no

Stated aim of study Quote “to observe the treatment of impaired glucose with Tangping san”.

Notes

Risk of bias table